Silence Therapeutics
SLN
$23.00
Share price
0.26%
Change (1 day)
322.02%
Change (1 year)
Categories
Silence Therapeutics (SLN) - P/B ratio
P/B ratio as of May 2024 : 49.3
According to Silence Therapeutics's latest financial reports the company has a price-to-book ratio of 49.3.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Silence Therapeutics - P/B ratio (from 2014 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 30.9 | 51.25% |
| 2022-12-31 | 20.5 | -63.32% |
| 2021-12-31 | 55.8 | 18.54% |
| 2020-12-31 | 47.1 | 258.74% |
| 2019-12-31 | 13.1 | 1137.54% |
| 2018-12-31 | 1.06 | |
| 2017-12-31 | N/A | |
| 2016-12-31 | N/A | -100% |
| 2015-12-31 | 1.93 | -50.36% |
| 2014-12-31 | 3.88 | |
| 2013-12-31 | N/A | |
| 2012-12-31 | N/A | |
| 2011-12-31 | N/A | |
| 2010-12-31 | N/A | |
| 2009-12-31 | N/A | |
| 2008-12-31 | N/A | |
| 2007-12-31 | N/A | |
| 2006-12-31 | N/A | |
| 2005-12-31 | N/A | |
| 2004-12-31 | N/A | |
| 2003-12-31 | N/A |